source
- Neumora drug fails two more Phase 3 trials, biotech to lay off 35% of staffThe Really Big Neuroscience Company is proving to be a Really Big Flop with each passing update. Neumora Therapeutics will discontinue its lead depression drug after it failed another two Phase 3 s…Endpoints · 2mo ago↗ source
- Six leaders working on LGBTQ+ inclusion in biopharmaIt’s been a tough 18 months for the LGBTQ+ community. The American Civil Liberties Union tracked 530 anti-LGBTQ bills across dozens of states this year. Nearly 40% of US workers say ...Endpoints · 2mo ago↗ source
- STAT+: Lilly’s Ajax acquisition may have been worth itA syphilis drug shortage, Sanofi's diabetes drug approval, and more biotech news from The ReadoutSTAT · 2mo ago↗ source